Literature DB >> 15250532

Current issues in managing group A streptococcal infections.

Jonathan R Carapetis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15250532     DOI： 10.1007/978-1-4419-8993-2_25

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  4 in total

1.  Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.

Authors:  Milagrosa Montes; Esther Tamayo; Beatriz Orden; Julián Larruskain; Emilio Perez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

Review 2.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

3.  Linoleic and palmitoleic acid block streptokinase-mediated plasminogen activation and reduce severity of invasive group A streptococcal infection.

Authors:  Katharina Rox; Rolf Jansen; Torsten G Loof; Christine M Gillen; Steffen Bernecker; Mark J Walker; Gursharan Singh Chhatwal; Rolf Müller
Journal:  Sci Rep       Date:  2017-09-18       Impact factor: 4.379

Review 4.  Invasive group a streptococcal disease: epidemiology, pathogenesis and management.

Authors:  Andrew C Steer; Theresa Lamagni; Nigel Curtis; Jonathan R Carapetis
Journal:  Drugs       Date:  2012-06-18       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.